|1.||Shen, Lin: 2 articles (11/2007 - 08/2007)|
|2.||Dai, Yi: 2 articles (11/2007 - 08/2007)|
|3.||Wang, Xiang: 1 article (05/2009)|
|4.||Wang, Li-Tong: 1 article (05/2009)|
|5.||Zhao, Yong-Fang: 1 article (05/2009)|
|6.||Zhan, Hong-Sheng: 1 article (05/2009)|
|7.||Chen, Yuan-Chuan: 1 article (05/2009)|
|8.||Xu, Yu: 1 article (05/2009)|
|9.||Yang, Yan-ping: 1 article (08/2007)|
08/01/2007 - "To study the effects of Migu Tablet (MGT) on bone mineral density (BMD), serum levels of osteoprotegerin (OPG) and its ligand (OPGL), and bone metabolic markers in patients with postmenopausal osteoporosis (PMO). "
11/01/2007 - "[Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis]."
08/01/2007 - "[Effects of Migu Tablet on bone mineral density, serum levels of osteoprotegerin and its ligand and bone metabolic markers in patients with postmenopausal osteoporosis]."
05/01/2009 - "Copy the model of osteoporosis by ovariectomy operation, the rats were randomly divided into four groups, pseudo-resection group, model group, Migu capsule group and strengthening Spleen prescriptions group. "
05/01/2009 - "Migu capsule and Strengthening Spleen prescriptions can cure osteoporosis by improving the expression of calf muscle VDR mRNA in the small intestine."
|2.||Matrix Metalloproteinase 2 (Gelatinase A)
|3.||Messenger RNA (mRNA)